成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

ChemicalBook
Chinese English Germany Korean

Shanghai Yifei Biotechnology Co. , Ltd. 企業(yè)の連絡(luò)先情報

名前:Shanghai Yifei Biotechnology Co. , Ltd.
電話番號:021-65675885
電子メール:customer_service@efebio.com
國籍:China
ウェブサイト:http://www.efebio.com
商品の合計數(shù):11974

製品カタログ

Talastineタラスチン16188-61-7C19H21N3O
UCM-132071621536-10-4
Isolupalbigeninイソルパルビゲニン162616-70-8C25H26O5
AC 7739162705-22-8C18H21NO4.ClH
JG-2311627126-59-3C22H18BrCl2N3OS4
Karavilagenin F1639024-15-9C31H50O5
Aprutumab1634620-63-5
BTA-98811646857-24-0C21H15ClN4O2
UniPR1291639159-47-9C36H52N2O4
GBT11181628799-51-8C19H20N2O4
Zilovertamab1643432-38-5
Leramistat1642602-54-7C20H21ClN2O3S
Itacnosertib1628870-27-8C26H28N8O
CRT-01059501661845-86-8C21H16ClN3OS
TL4-121620820-12-3C25H27F3N6O2
Ralaniten triacetate1637573-04-6C27H33ClO8
Ranevetmab1632282-27-9
Tavolixizumab1635395-25-3
Honokiol DCA1620160-42-0C22H18Cl4O4
MAO-B-IN-81638956-60-1C18H16O6
GNE-85051620573-48-9C21H24F3N5O
KZR-5041629052-78-3C21H23N3O6
TASP03903251642187-96-9C25H30Cl2FN5O4
(R)-DNMDP1630760-60-9C15H20N4O3
Ladiratuzumab1629760-28-6
TDRL-5511644626-43-6C25H23ClIN3O4
TAK-0201627603-21-7C18H17N5O3
Parthenosin166196-16-3C25H26O13
SLMP53-11643469-17-3C20H18N2O2
Naratuximab1622327-39-2
Vonlerolizumab1638935-72-4
Flotetuzumab1664355-28-5
Suvratoxumab1629620-18-3
Tomuzotuximab1646321-00-7
HTL142421644645-32-8C16H8ClFN4
Fluoroethylnormemantine hydrochloride1639210-25-5C12H21ClFN
(Rac)-Naxifylline166181-76-6C18H24N4O3
Dalzanemdor1629853-48-0C27H43F3O2
pan-HER-IN-21639040-95-1C19H15BrClN5O
BDBM505974311629853-49-1
Nerelimomab162774-06-3
Dapson-13C121632119-29-9
NDB1660153-08-1C26H28Cl2N2O2
ALDH2 modulator 11629615-99-1C18H18ClFN2O3
Selicrelumab1622140-49-1
Fluoroethylnormemantine1639210-26-6C12H20FN
ZEN-36941643947-30-1C19H19N5O
Clivatuzumab1622075-09-5
3-(Piperidin-4-yl)benzo[d]oxazol-2(3H)-one hydrochloride3-(ピペリジン-4-イル)ベンゾ[D]オキサゾール-2(3H)-オン塩酸塩162045-54-7C12H15ClN2O2
Rivabazumab1627519-84-9
Suptavumab1629615-23-1
Lupartumab1640971-88-5
Relatlimab1673516-98-7
PW04641643462-93-4C19H17F2N3O4
(Rac)-MEM 1003165187-25-7C22H25ClN2O5
Azido-PEG3-C6-Cl1625717-44-3
BrBzGCp2166038-00-2C27H38BrN3O6S
L-3726621-[2-メトキシ-4-[1-[(2-メチルピリジン1-オキシド)-3-イルメチル]-4-ピペリジニルオキシ]ベンゾイル]-4-[2-オキソ-2H-3,1-ベンゾオキサジン-1(4H)-イル]ピペリジン162045-26-3C33H38N4O6
VU04533791638646-27-1C26H34N4O2
PDK1-IN-RS21643958-89-7C15H9ClN2O2S3
Timigutuzumab1665274-14-5
Cipepofol1637741-58-2C14H20O
Nav1.8-IN-41620846-16-3C20H14F4N2O3
DA-68861645260-76-9C19H28Cl2N6O2
Glycopyrronium tosylateグリコピロニウムトシル酸塩水和物1624259-25-1C26H35NO6S
GS-6265101637770-13-8C25H22N4O
Laprituximab1622327-38-1
Frovocimab1643672-70-1
DI-821638148-50-1C20 H26 N6 O4 S3
Osimertinib-d61638281-44-3C28H33N7O2
CT-2584CT-2584166981-13-1C30H55N5O3
DHODH-IN-1716344-26-6C12H9ClN2O2
Eptinezumabエプチネズマブ(遺伝子組換え)1644539-04-7
Fremanezumabフレマネズマブ(遺伝子組換え)1655501-53-3
ABI-19681626364-18-8C35H58N5O6P
Otilimabオチリマブ(遺伝子組換え)1638332-55-4
Navicixizumab1638338-43-8
TGP-377/42116752-89-9C20H16N6
Ibiglustat succinate1629063-80-4C24H30FN3O6S
Vobarilizumab1628814-88-9
URAT1 inhibitor 71632002-28-8C19H10ClFN4O3S
FD-IN-11646682-14-5C23H23NO4
Gimsilumab1648796-29-5
Elsubrutinib1643570-24-4C17H19N3O2
CPL3041101627826-19-0C25H30N6O2
RS1-PDK1 inhibitorN-(6-クロロベンゾチアゾール-2-イル)ベンゾ[b]チオフェン-3-スルホンアミド1643958-85-3C15H9ClN2O2S3
Enrasentan167256-08-8C29H30O8
GPR81 agonist 11620992-67-7C22H30N4O2S2
MLK-IN-11627729-62-7C23H20N4O3S
TalviralineHBY-097163451-80-7C15H20N2O3S2
Zectivimod1623066-63-6C28H31Cl2N3O3
Inotuzumab1660159-36-3
Delmetacinデルメタシン16401-80-2C18H15NO3
(R)-AZD 96391646857-28-4C21H15ClN4O2
ACT-6606021646267-59-5C20H20F6N8OS
FGFR4-IN-51628793-01-0C23H23Cl2N5O5
AGN 192870166977-57-7C27H22O2
hTYR/AbTYR-IN-11625821-37-5C18H20N2O3
Gü26021627094-88-5C16H22N4O3
(Rac)-Telinavir162679-88-1C33H44N6O5
Copyright 2017 ? ChemicalBook. All rights reserved